Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin

Eugenia M Yazlovitskaya1, Diane L Persons

  • 1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160, USA.

Anticancer Research
|August 5, 2003
PubMed

Insights

Cisplatin affects DNA damage response kinases, increasing ATR activity. Caffeine enhances cisplatin

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Ataxia teleangiectasia mutated (ATM) kinase, ATM-Rad3-related (ATR) kinase, and DNA-protein kinase (DNA-PK) are key regulators of the DNA damage response.
  • Understanding how these kinases are modulated by chemotherapeutic agents is crucial for improving cancer treatment.

Purpose of the Study:

  • To investigate the effects of cisplatin on ATM, ATR, and DNA-PK activities.
  • To explore the role of ATR inhibition by caffeine in modulating cisplatin's cytotoxic effects and downstream signaling pathways.

Main Methods:

  • Assessing kinase activities (ATM, ATR, DNA-PK) following cisplatin treatment.
  • Evaluating the impact of caffeine, an ATR inhibitor, on cisplatin cytotoxicity.
  • Analyzing the modulation of key proteins (p53, p21WAF-1, cdc2-p34/cyclin B1 complex) in response to cisplatin and caffeine.

Main Results:

  • Cisplatin increased ATR activity while decreasing ATM and DNA-PK activity.
  • Caffeine enhanced the cytotoxic effect of cisplatin.
  • Caffeine treatment led to decreased p53 and p21WAF-1 response and altered the cdc2-p34/cyclin B1 complex.

Conclusions:

  • ATR kinase activity is modulated by cisplatin.
  • Inhibition of ATR activity by caffeine may be a mechanism underlying caffeine's regulation of cisplatin sensitivity.
  • Targeting ATR could be a strategy to enhance chemotherapy efficacy.